Trial Profile
Factors Associated to Success of Hepatitis C Therapy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2009
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Interferon; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 25 Mar 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 25 Mar 2009 Actual initiation date (Aug 2007) added as reported by ClinicalTrials.gov.
- 25 Mar 2009 Actual patient number (100) added as reported by ClinicalTrials.gov.